A review of expanding options that hold new promise
Blinatumomab followed by POMP maintenance shows effectiveness for newly diagnosed patients
Finally, promising new therapies for this difficult disease
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy